NHS: the UK's not so secret weapon against COVID-19

National Institute for Health and Care Research

Contenu fourni par NIHR. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par NIHR ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.

3+ y ago 13:35

MP3•Maison d'episode

View the accessible transcript of this podcast
Professor Sir Munir Pirmohamed talks to Professor Allan Gaw about how the UK was able to rapidly adapt to the quest to find new treatments for COVID-19.
He points to key ingredients such as the NIHR research workforce, fast-tracked funding decisions, reduced bureaucracy, collaborative research culture - all of which contributed to the UK's success. Importantly, he also recognises that none of this could have been possible without the infrastructure and data systems provided by the NHS and he explains how the UK's integrated health research system was critical to the delivery of the hugely successful COVID-19 platform trials.
This podcast is part of our 'Persectives from the Pandemic' series looking at the delivery of Complex and Innovative Design (CID) trials in the COVID-19 pandemic. You can access the full series of #ComplexInnovativeDesign trial podcasts on our website: www.nihr.ac.uk/documents/delivering-complex-and-innovative-trials-podcast-collection/29517
To find out more about how the NIHR supports complex and innovative design trials, visit: www.nihr.ac.uk/innovative-trials

52 episodes

#Science #NIHR #Life Sciences #Research #Health and Well-Being #Funding